These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11094653)

  • 1. Enhancement of a pharmacy consultation program on a transitional care unit.
    Follin SL; Kwong NM
    Am J Health Syst Pharm; 2000 Nov; 57(21):1990-3. PubMed ID: 11094653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of an emergency department pharmacy program during economically challenging times.
    Nana B; Lee-Such S; Allen G
    Am J Health Syst Pharm; 2012 Oct; 69(19):1682-6. PubMed ID: 22997122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and implementation of an interdisciplinary oncology program in a community hospital.
    Chung C; Collins A; Cui N
    Am J Health Syst Pharm; 2011 Sep; 68(18):1740-7. PubMed ID: 21880891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and evaluation of a team-based pharmacy practice model in a community health system.
    Gill TK; Thornton LM; Schroeder TR; Garrelts JC; Schminke BC; Utz KJ; Gerlach CT
    Am J Health Syst Pharm; 2019 Mar; 76(7):470-477. PubMed ID: 31415682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the impact of telepharmacy.
    Schneider PJ
    Am J Health Syst Pharm; 2013 Dec; 70(23):2130-5. PubMed ID: 24249763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
    Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
    Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of clinical pharmacy services in a community hospital.
    Williams LE
    Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy team providing enhanced services to a transitional care unit.
    Boord AS; Sanders SL; Bass LW; Benson BD; Clark GM; Meyer SK
    Am J Health Syst Pharm; 2007 Mar; 64(6):647-51. PubMed ID: 17353575
    [No Abstract]   [Full Text] [Related]  

  • 9. Documentation of cost savings from decentralized clinical pharmacy services at a community hospital.
    Taylor JT; Kathman MS
    Am J Hosp Pharm; 1991 Jul; 48(7):1467-70. PubMed ID: 1882875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical services provided by staff pharmacists in a community hospital.
    Garrelts JC; Smith DF
    Am J Hosp Pharm; 1990 Sep; 47(9):2011-5. PubMed ID: 2244945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-managed intravenous to oral step-down program.
    Hunter KA; Dormaier GK
    Clin Ther; 1995; 17(3):534-40; discussion 516. PubMed ID: 7585857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.
    Erstad BL; Haas CE; O'Keeffe T; Hokula CA; Parrinello K; Theodorou AA
    Pharmacotherapy; 2011 Feb; 31(2):128-37. PubMed ID: 21275491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital pharmacy services in the Great Lakes region.
    Raehl CL; Bond CA; Pitterle ME
    Am J Hosp Pharm; 1990 Jun; 47(6):1283-303. PubMed ID: 2368722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unit.
    Rosenbaum CL; Fant WK; Miyagawa CI; Armitstead JA
    Am J Hosp Pharm; 1991 Oct; 48(10):2154-7. PubMed ID: 1781471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical coordinator.
    Catania HF; Yee WP; Catania PN
    Am J Hosp Pharm; 1990 Dec; 47(12):2701-5. PubMed ID: 2278286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a bone marrow transplant satellite pharmacy.
    Woloschuk DM; Nazeravich DR; Gray LJ; Larter JM
    Can J Hosp Pharm; 1993 Feb; 46(1):5-11. PubMed ID: 10124614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.
    Valgus JM; Faso A; Gregory KM; Jarr S; Savage S; Caiola S; Walko CM; Kim J; Bernard SA
    Am J Health Syst Pharm; 2011 Apr; 68(7):613-9. PubMed ID: 21411803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of drug-related problems in home care patients through a pharmacy referral service.
    Triller DM; Clause SL; Briceland LL; Hamilton RA
    Am J Health Syst Pharm; 2003 May; 60(9):905-10. PubMed ID: 12756941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.